COVID 19 vaccine
Aug 06, 2020
Zydus starts Phase II COVID-19 vaccine trial; Taysha raises $95M; FDA declines DBV’s peanut allergy patch; Combating COVID-19 with decoy target
Zydus starts phase 2 COVID-19 vaccine trial after clearing safety test Zydus Cadila has finished a phase 1 clinical trial of its COVID-19 vaccine ZyCoV-D, setting it up to move straight into a 1,000-subject phase 2 study. The Indian company informed that the DNA vaccine was well tolerated in the first stage of t...
Read More...
May 19, 2020
Moderna’s COVID-19 Vaccine; Quidel’s Lyra gets EUA from FDA; Neurotrope and Metuchen Pharma Announced Merger Agreement; FDA Approval to Rucaparib;
Moderna Therapeutics has announced the positive results of trials of its COVID-19 vaccine, mRNA-1273. The results of interim Phase I clinical trial showed promising outcomes in terms of efficacy and tolerability and potential of mRNA-1273 against COVID-19. The company received the funds for conductin...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
